Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab and Male Infertility
2016-003546-84Phase 2Completed
- Sponsor
- Department of Growth and Reproduction
- Start
- Sep 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in male infertility comparing Denosumab with Placebo (2 arms). Primary endpoint: Change in semen production. Started Sep 2016; status: completed.
02
Drugs
denosumab
03
Conditions
male infertility
Beyond the preview
Go deeper on 2016-003546-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003546-84.